Fundraising Fox
Collegium Pharmaceutical
NASDAQ: COLLCanton, US · Virginia corporation · 488 employees on LinkedIn · 6 known investors
Find your way into Collegium Pharmaceutical
Sign up to see every warm intro you have to Collegium Pharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Collegium Pharmaceutical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.
Founders & leadership
Board
Investors · 6
How we know: APERTURE Venture Partners's portfolio page · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$92.5M disclosed across 3 rounds · 2012–2018
▶$20MraisedNov 2018 · 1 investors · PharmaceuticalsRule 506(b)
- Michael HeffernanDirector
- David HirschDirector
- Garen BohlinDirector
- Shirley KuhlmannExecutive Officer
- Theodore SchroederDirector
- John A FallonDirector
- Alison B. FlemingExecutive Officer
- Gwen MelincoffDirector
- Gino SantiniDirector
- Scott DreyerExecutive Officer
- Joseph CiaffoniExecutive Officer, Director
- John FreundDirector
- Paul BrannellyExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Nov 2018
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$50MraisedMar 2015 · 18 investors · PharmaceuticalsRule 506(b)
- Gino SantiniDirector
- Eran NadavDirector
- John FreundDirector
- Patrick HeronDirector
- Garen BohlinDirector
- David HirschDirector
- Michael HeffernanExecutive Officer, Director
- Paul BrannellyExecutive Officer
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Mar 2015
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$22.5MraisedFeb 2012 · 12 investors · PharmaceuticalsRule 506(b)
- David HirschDirector
- Patrick HeronDirector
- Patrick FortuneDirector
- Michael HeffernanExecutive Officer, Director
- Stephen HoffmanDirector
- Offering amount
- $22.5M
- Amount sold
- $22.5M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Collegium Pharmaceutical went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Collegium Pharmaceutical.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $472.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Acquisitions · 1
Early investors' stakes continue via these dealsBioDelivery Sciences International was a specialty pharmaceutical company developing pain and neurology treatments, including the opioid product BELBUCA and migraine drug Elyxyb.
Frequently asked questions
- What does Collegium Pharmaceutical do?
- Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.
- Who founded Collegium Pharmaceutical?
- Collegium Pharmaceutical was founded by Michael Heffernan.
- Who are Collegium Pharmaceutical's investors?
- Collegium Pharmaceutical's investors include APERTURE Venture Partners, EcoR1 Capital, Frazier Life Sciences, Longitude Capital, Boston Millennia Partners, RA Capital.
- How much funding has Collegium Pharmaceutical raised?
- Collegium Pharmaceutical has disclosed $92.5M raised across 3 rounds.
- Where is Collegium Pharmaceutical headquartered?
- Collegium Pharmaceutical is headquartered in Canton, US.